n-acetylcysteinamide has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AU; Auffinger, B; Kim, CK; Lesniak, MS; Moon, KS; Tobias, AL; Ulasov, IV | 1 |
| Congdon, KL; Sampson, JH | 1 |
2 other study(ies) available for n-acetylcysteinamide and Glial Cell Tumors
| Article | Year |
|---|---|
N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy.
Topics: Acetylcysteine; Adenoviridae; Animals; Cell Line, Tumor; Glioma; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasms, Experimental; Neural Stem Cells; Oncolytic Virotherapy; Oncolytic Viruses; Virus Replication; Xenograft Model Antitumor Assays | 2013 |
Enhanced oncolytic virotherapy through oxidative stress inhibition.
Topics: Acetylcysteine; Adenoviridae; Animals; Glioma; Neural Stem Cells; Oncolytic Virotherapy | 2013 |